{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-08-13T12:23:46.577153+00:00",
  "news": [
    {
      "title": "Stock Analysis | Amgen Outlook - Technical Neutrality and Mixed Analyst Expectations - AInvest",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQSlg4UDNkWXc1aFZTM2JRbEtVcmlmY1dIZ2NxMFFpSFRjdWk0OGFSNVVPSW5vMFhzbkM2eUxDVGk3N1RqSFA0XzZEN0k2WG1UNmd2Vno0b2c3Rml4SWc2d1JkQWxHQUozZzRCaGJJNEIxa19kazNMMnRiX3dBQy0zcVp2LUQ0Qk1hVzlZdy1uYXZtOXl1S0ZPelNBLVM1RFFTMlFUT1BNWlhuX2hFZjlYSQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxQSlg4UDNkWXc1aFZTM2JRbEtVcmlmY1dIZ2NxMFFpSFRjdWk0OGFSNVVPSW5vMFhzbkM2eUxDVGk3N1RqSFA0XzZEN0k2WG1UNmd2Vno0b2c3Rml4SWc2d1JkQWxHQUozZzRCaGJJNEIxa19kazNMMnRiX3dBQy0zcVp2LUQ0Qk1hVzlZdy1uYXZtOXl1S0ZPelNBLVM1RFFTMlFUT1BNWlhuX2hFZjlYSQ?oc=5\" target=\"_blank\">Stock Analysis | Amgen Outlook - Technical Neutrality and Mixed Analyst Expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-13T06:48:11+00:00",
      "source": "AInvest"
    },
    {
      "title": "5 Insightful Analyst Questions From Amgen’s Q2 Earnings Call - ca.finance.yahoo.com",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOTVV2QkRRVGNwWjRyWnlkWHR1Xy1sWmE4a21KYzZLT1ZEekR2WENzMFpDUm12dEJQWUthc0Vpck9hN24wZldFOGFQVnNuOTZGZFZSZl8tQURsZkhGMFZiOXBZcGp2S1FwZmgtQUNUU0JBbHlHcXNhTDR2dmJ4UDdFaS1xbWF3N0NMaE5JUS1B?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxOTVV2QkRRVGNwWjRyWnlkWHR1Xy1sWmE4a21KYzZLT1ZEekR2WENzMFpDUm12dEJQWUthc0Vpck9hN24wZldFOGFQVnNuOTZGZFZSZl8tQURsZkhGMFZiOXBZcGp2S1FwZmgtQUNUU0JBbHlHcXNhTDR2dmJ4UDdFaS1xbWF3N0NMaE5JUS1B?oc=5\" target=\"_blank\">5 Insightful Analyst Questions From Amgen’s Q2 Earnings Call</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">ca.finance.yahoo.com</font>",
      "published": "2025-08-13T03:59:00+00:00",
      "source": "ca.finance.yahoo.com"
    },
    {
      "title": "Resona Asset Management Co. Ltd. Buys 13,390 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPM0RPbjd3bk84NGRRY1VhaTBGNFdFbGRkUWZTcHp6RFAwOVNNQThvbGdBQTYyTGk1amNsNHkycTQ2MGd0TmUzaTJGZi1pUW1NSDJmdkYyTHZFSXVnc04wd0FPeURPb2NGaWxXbXVndTM4V2U2cTZNekxmYS1XT2VMcTRDZnhlVVhxWWdfeEN6SC1uNHBXdF9mZHlYbkRGNHhpVFU5ZUljWGVHS3hGSEpTejc1WFpxV0RKZzF2cERYX1VVN1BSR05MaWhsQ2Jwdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMizgFBVV95cUxPM0RPbjd3bk84NGRRY1VhaTBGNFdFbGRkUWZTcHp6RFAwOVNNQThvbGdBQTYyTGk1amNsNHkycTQ2MGd0TmUzaTJGZi1pUW1NSDJmdkYyTHZFSXVnc04wd0FPeURPb2NGaWxXbXVndTM4V2U2cTZNekxmYS1XT2VMcTRDZnhlVVhxWWdfeEN6SC1uNHBXdF9mZHlYbkRGNHhpVFU5ZUljWGVHS3hGSEpTejc1WFpxV0RKZzF2cERYX1VVN1BSR05MaWhsQ2Jwdw?oc=5\" target=\"_blank\">Resona Asset Management Co. Ltd. Buys 13,390 Shares of Amgen Inc. (NASDAQ:AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-08-13T11:51:03+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "S&P Pharma Giant Stumbles On Obesity Questions - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxNN29qeDRmUjg0MUxQd1lpMnlrcVZVY2ZhdVluVHZnTnhJaEE0YWQwSDUtMG5MSDRPVnFySUR4S0RBLXUzQzJSS2ZPMnh4Y3BRdDNBc21UWjBqU0lhanlLYXhrU1g0ci00Uk5mdWh4dkFBbFdIekdRTXh4RUF6RG1OYU5hSQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxNN29qeDRmUjg0MUxQd1lpMnlrcVZVY2ZhdVluVHZnTnhJaEE0YWQwSDUtMG5MSDRPVnFySUR4S0RBLXUzQzJSS2ZPMnh4Y3BRdDNBc21UWjBqU0lhanlLYXhrU1g0ci00Uk5mdWh4dkFBbFdIekdRTXh4RUF6RG1OYU5hSQ?oc=5\" target=\"_blank\">S&amp;P Pharma Giant Stumbles On Obesity Questions</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-08-06T20:23:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "AMGEN REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQSWhKMFgxZFhXQTJQWFZxN0FxTXNZQmUxcVNWcURLRGx2Y2VEazFUdEQwRTg3YVA4OWIzWlBxbXBrdlpaSjhBRmRKd0lHejlLS3Z5ZU5acVdMUmpHMnlJZS16c1NLWm9UMEdkeTQ1VFI3YUxXY1VmWGhDb2pWRmxOWFRYN3FaQjZFZkxnVjJsbWdCMU54UHk1R2lXQTRPc3pyNlk0VGtCSXFkT3M?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQSWhKMFgxZFhXQTJQWFZxN0FxTXNZQmUxcVNWcURLRGx2Y2VEazFUdEQwRTg3YVA4OWIzWlBxbXBrdlpaSjhBRmRKd0lHejlLS3Z5ZU5acVdMUmpHMnlJZS16c1NLWm9UMEdkeTQ1VFI3YUxXY1VmWGhDb2pWRmxOWFRYN3FaQjZFZkxnVjJsbWdCMU54UHk1R2lXQTRPc3pyNlk0VGtCSXFkT3M?oc=5\" target=\"_blank\">AMGEN REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-08-05T20:01:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Generative AI Tools Support Amgen’s Mission to Serve Patients - Amgen",
      "link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNMmdNbVVGa2tCTHRkdGFsbm9LaFUyOWFpTXhMeGotQTFoOXpuRFBpemY4b0o1aWRrQ1hHUFZua3hWV3FkWUlUUmUyRXZsbTdzRXV1eDlqcjZEbjZkMnV6SHNqM2c2WE1QS2hEYTdsV2RUMWt6OE9GbjUxaEtUMTYzWEF0NjV3S19kOHRrUTdPQWR2ZVZqVk9DRTh0OHFRTm8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinwFBVV95cUxNMmdNbVVGa2tCTHRkdGFsbm9LaFUyOWFpTXhMeGotQTFoOXpuRFBpemY4b0o1aWRrQ1hHUFZua3hWV3FkWUlUUmUyRXZsbTdzRXV1eDlqcjZEbjZkMnV6SHNqM2c2WE1QS2hEYTdsV2RUMWt6OE9GbjUxaEtUMTYzWEF0NjV3S19kOHRrUTdPQWR2ZVZqVk9DRTh0OHFRTm8?oc=5\" target=\"_blank\">Generative AI Tools Support Amgen’s Mission to Serve Patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-07-08T07:00:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "Doctored data, protest from trial observers: Lawsuit points to alleged misconduct at Amgen-bought biotech - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQem90RTNYZVd3VG9TYTZ6dHRWVkx2WXJCYXd0TktCbmlBOE15bHk2OHF5ZGFVNmM1Uy02ZE0wdHlUUmNoVDgyWFQzSUxkMElKNUQ0SmVaTl9XOEVKODRZNGdOREhYZVJ6MFVKLWotVnNaanFONm03a2JGNHZHeWJvdExwMWdTWXNkNm1nRzhzRmhCcDNyNExrZS1hM1FhcGI1M3p6dDU3LU9ZOTFGQ3NhRDA4SUtRWmUzNXZ5NW5pVllZX1k?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQem90RTNYZVd3VG9TYTZ6dHRWVkx2WXJCYXd0TktCbmlBOE15bHk2OHF5ZGFVNmM1Uy02ZE0wdHlUUmNoVDgyWFQzSUxkMElKNUQ0SmVaTl9XOEVKODRZNGdOREhYZVJ6MFVKLWotVnNaanFONm03a2JGNHZHeWJvdExwMWdTWXNkNm1nRzhzRmhCcDNyNExrZS1hM1FhcGI1M3p6dDU3LU9ZOTFGQ3NhRDA4SUtRWmUzNXZ5NW5pVllZX1k?oc=5\" target=\"_blank\">Doctored data, protest from trial observers: Lawsuit points to alleged misconduct at Amgen-bought biotech</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-07-25T07:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Amgen Inc. (NASDAQ:AMGN) Shares Sold by Westpac Banking Corp - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOT2VqVWpGWVdRWXpUMkFlUEVJMVNoWTV0dFAtZTZOd0sxV0lFU0xJc25TMmhUR3ZOa3ZCMG9DemdrY0c1bWlCQW1KV0pUY3l0Z2J4WVg5aE5TWWNuMDdnQnNVdnFLNU9uaEdTSVlYeFFzS0VtM3pJeERBMEl5S3c2aEs0VG9wSkRDZ3k0VnpXNWFmOERIb1hCQXBhb3RPV0hKdkF3QWotMEs2RmFRQUwzSWVGX2Frc0xC?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOT2VqVWpGWVdRWXpUMkFlUEVJMVNoWTV0dFAtZTZOd0sxV0lFU0xJc25TMmhUR3ZOa3ZCMG9DemdrY0c1bWlCQW1KV0pUY3l0Z2J4WVg5aE5TWWNuMDdnQnNVdnFLNU9uaEdTSVlYeFFzS0VtM3pJeERBMEl5S3c2aEs0VG9wSkRDZ3k0VnpXNWFmOERIb1hCQXBhb3RPV0hKdkF3QWotMEs2RmFRQUwzSWVGX2Frc0xC?oc=5\" target=\"_blank\">Amgen Inc. (NASDAQ:AMGN) Shares Sold by Westpac Banking Corp</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-08-13T10:52:47+00:00",
      "source": "MarketBeat"
    }
  ],
  "product_launches": [
    {
      "title": "Boryung launches Samsung Bioepis' bone cancer biosimilar with storage edge over Amgen's Xgeva - koreabiomed.com",
      "link": "https://news.google.com/rss/articles/CBMibkFVX3lxTE51eEtJYkhkRHFlaDJiREhrQ3FTNFpINXVRT2xkNUo1dFROdWJLUF9fcm9EWVNWeW44S2JmR2FwQWpERUxRODRaTkZWRmpmQmFjWkQ5b0NaVm5DY005ZGlhTzQ4T2Z3ejJkT202am1R0gFyQVVfeXFMTWR6QWpUU2tQdnNiYmF2clROVVFIU2NFQzdnV3JOZUF0cHVaYVVmYTk0a01CSjA5N3ZMcnpZSllXWHhtWXZocnJySlgtMjhrbS1Yd1pIdEdOSzVVczllV0tFRHZRRjJ0dnJvbjZKOEdGandn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMibkFVX3lxTE51eEtJYkhkRHFlaDJiREhrQ3FTNFpINXVRT2xkNUo1dFROdWJLUF9fcm9EWVNWeW44S2JmR2FwQWpERUxRODRaTkZWRmpmQmFjWkQ5b0NaVm5DY005ZGlhTzQ4T2Z3ejJkT202am1R0gFyQVVfeXFMTWR6QWpUU2tQdnNiYmF2clROVVFIU2NFQzdnV3JOZUF0cHVaYVVmYTk0a01CSjA5N3ZMcnpZSllXWHhtWXZocnJySlgtMjhrbS1Yd1pIdEdOSzVVczllV0tFRHZRRjJ0dnJvbjZKOEdGandn?oc=5\" target=\"_blank\">Boryung launches Samsung Bioepis' bone cancer biosimilar with storage edge over Amgen's Xgeva</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">koreabiomed.com</font>",
      "published": "2025-08-04T01:50:03+00:00",
      "source": "koreabiomed.com"
    },
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Amgen Confirms Launch Of First US Eculizumab Rival - insights.citeline.com",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5\" target=\"_blank\">Amgen Confirms Launch Of First US Eculizumab Rival</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>",
      "published": "2025-03-05T08:00:00+00:00",
      "source": "insights.citeline.com"
    },
    {
      "title": "Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US - firstwordpharma.com",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5\" target=\"_blank\">Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">firstwordpharma.com</font>",
      "published": "2025-04-14T07:00:00+00:00",
      "source": "firstwordpharma.com"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-08-12",
      "close": 284.9800109863281
    },
    "history": [
      {
        "date": "2025-08-04",
        "close": 301.94000244140625
      },
      {
        "date": "2025-08-05",
        "close": 300.0799865722656
      },
      {
        "date": "2025-08-06",
        "close": 284.6700134277344
      },
      {
        "date": "2025-08-07",
        "close": 284.70001220703125
      },
      {
        "date": "2025-08-08",
        "close": 288.2300109863281
      },
      {
        "date": "2025-08-11",
        "close": 285.0899963378906
      },
      {
        "date": "2025-08-12",
        "close": 284.9800109863281
      }
    ],
    "name": "Amgen Inc."
  }
}